311 related articles for article (PubMed ID: 7639617)
1. Tachykinin receptors and receptor subtypes.
Patacchini R; Maggi CA
Arch Int Pharmacodyn Ther; 1995; 329(1):161-84. PubMed ID: 7639617
[TBL] [Abstract][Full Text] [Related]
2. Activity of cyclic pseudopeptide antagonists at peripheral tachykinin receptors.
Patacchini R; Quartara L; Astolfi M; Goso C; Giachetti A; Maggi CA
J Pharmacol Exp Ther; 1995 Mar; 272(3):1082-7. PubMed ID: 7891319
[TBL] [Abstract][Full Text] [Related]
3. Tachykinins and tachykinin receptors in bone.
Goto T; Tanaka T
Microsc Res Tech; 2002 Jul; 58(2):91-7. PubMed ID: 12203708
[TBL] [Abstract][Full Text] [Related]
4. Characterization of receptors mediating contraction induced by tachykinins in the guinea-pig isolated common bile duct.
Patacchini R; Barthó L; Maggi CA
Br J Pharmacol; 1997 Dec; 122(8):1633-8. PubMed ID: 9422808
[TBL] [Abstract][Full Text] [Related]
5. Characterization of tachykinin receptors in the uterus of the oestrogen-primed rat.
Magraner J; Pinto FM; Anselmi E; Hernandez M; Perez-Afonso R; Martín JD; Advenier C; Candenas ML
Br J Pharmacol; 1998 Jan; 123(2):259-68. PubMed ID: 9489614
[TBL] [Abstract][Full Text] [Related]
6. The mammalian tachykinin receptors.
Maggi CA
Gen Pharmacol; 1995 Sep; 26(5):911-44. PubMed ID: 7557266
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of ZD6021: a novel, orally active antagonist of the tachykinin receptors.
Rumsey WL; Aharony D; Bialecki RA; Abbott BM; Barthlow HG; Caccese R; Ghanekar S; Lengel D; McCarthy M; Wenrich B; Undem B; Ohnmacht C; Shenvi A; Albert JS; Brown F; Bernstein PR; Russell K
J Pharmacol Exp Ther; 2001 Jul; 298(1):307-15. PubMed ID: 11408556
[TBL] [Abstract][Full Text] [Related]
8. MEN 11420 (Nepadutant), a novel glycosylated bicyclic peptide tachykinin NK2 receptor antagonist.
Catalioto RM; Criscuoli M; Cucchi P; Giachetti A; Gianotti D; Giuliani S; Lecci A; Lippi A; Patacchini R; Quartara L; Renzetti AR; Tramontana M; Arcamone F; Maggi CA
Br J Pharmacol; 1998 Jan; 123(1):81-91. PubMed ID: 9484857
[TBL] [Abstract][Full Text] [Related]
9. Effect of scyliorhinin I and synthetic scyliorhinin I derivatives at mammalian tachykinin NK1, NK2 and NK3 receptors.
Patacchini R; Quartara L; Rolka K; Zboinska J; Kupryszewski G; Maggi CA
Eur J Pharmacol; 1993 Dec; 250(2):311-6. PubMed ID: 7509285
[TBL] [Abstract][Full Text] [Related]
10. Neurokinin-receptor antagonists: pharmacological tools and therapeutic drugs.
Longmore J; Hill RG; Hargreaves RJ
Can J Physiol Pharmacol; 1997 Jun; 75(6):612-21. PubMed ID: 9276138
[TBL] [Abstract][Full Text] [Related]
11. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of tachykinin NK2-receptors modulating motor responses of human colonic muscle strips.
Croci T; Aureggi G; Manara L; Emonds-Alt X; Le Fur G; Maffrand JP; Mukenge S; Ferla G
Br J Pharmacol; 1998 Jul; 124(6):1321-7. PubMed ID: 9720807
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin receptors (NK1, NK2) in the mouse: a pharmacological study.
Nsa Allogho S; Nguyen-Le XK; Gobeil F; Pheng LH; Regoli D
Can J Physiol Pharmacol; 1997 Jun; 75(6):552-7. PubMed ID: 9276127
[TBL] [Abstract][Full Text] [Related]
14. MEN15596, a novel nonpeptide tachykinin NK2 receptor antagonist.
Cialdai C; Tramontana M; Patacchini R; Lecci A; Catalani C; Catalioto RM; Meini S; Valenti C; Altamura M; Giuliani S; Maggi CA
Eur J Pharmacol; 2006 Nov; 549(1-3):140-8. PubMed ID: 16979621
[TBL] [Abstract][Full Text] [Related]
15. Recent advances in neurokinin receptor antagonists.
Gao Z; Peet NP
Curr Med Chem; 1999 May; 6(5):375-88. PubMed ID: 10101218
[TBL] [Abstract][Full Text] [Related]
16. SSR240600 [(R)-2-(1-[2-[4-[2-[3,5-bis(trifluoromethyl)phenyl]acetyl]-2-(3,4-dichlorophenyl)-2-morpholinyl]ethyl]- 4-piperidinyl)-2-methylpropanamide], a centrally active nonpeptide antagonist of the tachykinin neurokinin-1 receptor: I. biochemical and pharmacological characterization.
Emonds-Alt X; Proietto V; Steinberg R; Oury-Donat F; Vigé X; Vilain P; Naline E; Daoui S; Advenier C; Le Fur G; Maffrand JP; Soubrié P; Pascal M
J Pharmacol Exp Ther; 2002 Dec; 303(3):1171-9. PubMed ID: 12438541
[TBL] [Abstract][Full Text] [Related]
17. [Functional properties of tachykinin receptors in the central nervous system].
Glowinski J; Beaujouan JC
C R Seances Soc Biol Fil; 1993; 187(1):62-8. PubMed ID: 8242423
[TBL] [Abstract][Full Text] [Related]
18. Functional and molecular characterization of tachykinins and tachykinin receptors in the mouse uterus.
Patak E; Pinto FM; Story ME; Pintado CO; Fleming A; Page NM; Pennefather JN; Candenas ML
Biol Reprod; 2005 May; 72(5):1125-33. PubMed ID: 15647454
[TBL] [Abstract][Full Text] [Related]
19. Neurokinin receptors subserving bronchoconstriction.
Ellis JL
Can J Physiol Pharmacol; 1995 Jul; 73(7):923-6. PubMed ID: 8846431
[TBL] [Abstract][Full Text] [Related]
20. Chimeric NK1 (substance P)/NK3 (neurokinin B) receptors. Identification of domains determining the binding specificity of tachykinin agonists.
Gether U; Johansen TE; Schwartz TW
J Biol Chem; 1993 Apr; 268(11):7893-8. PubMed ID: 7681831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]